JESSICA RUSHING: Open Payments
NPI 1023414141 · CONROE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,873 in 92 payments from 19 companies in 2025. Trend: 2023 $2,172 · 2024 $1,466 · 2025 $1,873
Food & beverage: $1,733Education: $140
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $389 |
| ABBVIE INC. | 15 | $249 |
| Novartis Pharmaceuticals Corporation | 11 | $243 |
| Galderma Laboratories, L.P. | 14 | $190 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $182 |
| GENZYME CORPORATION | 4 | $125 |
| Incyte Corporation | 4 | $80 |
| Amgen Inc. | 4 | $79 |
| Medline Industries LP | 1 | $70 |
| Arcutis Biotherapeutics, Inc. | 3 | $54 |
Products named: TREMFYA, COSENTYX, SKYRIZI, DUPIXENT, RINVOQ, ILUMYA, AKLIEF, OPZELURA.
Industry payments across TX — which companies pay providers there.
